Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
ADMA Biologics Announces Pricing of Public Offering of Common Stock
-
Chipotle Mexican Grill's (CMG) Price Target Lowered to $300 at Maxim
-
The Vatican Hosts Third International Regenerative Medicine Conference
-
CORRECTING and REPLACING The Vatican Hosts Third International Regenerative Medicine Conference
-
Chipotle's troubles might help Panera as both serve up reports
-
Streetinsider.com's Hot Lunchtime Reads 4/25: (RLYP) (P) (AVXL) (PRGO)
-
Maxim Group Weighs in on Anavex Life Sciences (AVXL) Following Positive Anecdotal Aussie News Story
-
Jensyn Acquisition Corp. Announces Termination of Over-Allotment Option and Common Stock, Rights and Warrants to Commence Separate Trading on or about April 25, 2016
-
Prima BioMed Ltd (PBMD) Adds to Early Gains
-
Streetinsider.com's Hot Lunchtime Reads 4/20: (NVS) (BLUE) (MSFT) (DISH)
-
bluebird bio (BLU) Bullish View Reiterated at Maxim Group as Lenti-D Continues to Show Signs of Efficacy in CCALD
-
Maxim Group Reiterates Positive View on Oculus Innovative (OCLS) Following 510(k) Clearance
-
Maxim Group Starts QCR Holdings (QCRH) at Buy
-
Over 100 Companies Speaking at Parks Associates' 20th-Annual CONNECTIONS: The Premier Connected Home Conference, May 24-26 in San Francisco
-
Maxim Group Starts Prima Biomed (PBMD) at Buy, $4 PT
-
The PIPEs Report Sees Small-Cap Equity Financing Growth at the End of Q1 2016
-
Maxim Group LLC Expands Equity Research With the Appointment of a Consumer Analyst
-
Maxim Group Starts BioPharmX Corp (BPMX) at Buy
-
Viking Therapeutics Announces Closing of Public Offering of Common Stock and Warrants
-
Maxim Group Starts Ritter Pharmaceuticals (RTTR) at Buy, $7 PT
-
Maxim Group Downgrades Domino's Pizza (DPZ) to Hold
-
PlacementTracker Publishes Q1 2016 PIPE Market League Tables
-
Juno's (JUNO) New Company Brings First Mover Advantage to China - Maxim
-
Viking Therapeutics (VKTX) Prices Common Stock and Warrant Offering for Proceeds of $9.38M
-
Viking Therapeutics Announces Pricing of Public Offering of Common Stock and Warrants
-
Maxim Group Assumes Biostage (BSTG) at Buy, $8 PT
-
Cytori Therapeutics (CYTX) Discloses $11M Rights Offering
-
Galmed Pharma (GLMD) Surges 38%
-
Starboard's Jeff Smith resigns as Darden chairman
-
Streetinsider.com's Hot Lunchtime Reads 4/4: (ESI) (AAPL) (RKUS) (GLMD)
-
Galmed Pharma (GLMD) May Be Worth $24/Share Based on Gilead's Nimbus Deal - Maxim Group
-
BioPharmX Corporation Announces Closing Of $4.3 Million Public Offering
-
Maxim Group Starts County Bancorp (ICBK) at Buy
-
RiceBran Technologies President and CEO to be a Featured Panelist at the Health, Wellness & Better Eating Conference
-
Chris Reed to Speak on Panel at the Maxim Group Health, Wellness & Better Eating Conference
-
Keryx Biopharmaceuticals (KERX) PT Rasied to $7 at Maxim Group Following Positive Study
-
BioPharmX (BPMX) Prices $4.3M Common Stock, Warrants Offering
-
BioPharmX Corporation Announces Pricing Of Public Offering To Raise $4.3 Million
-
Maxim Group Raises Price Target on Adamis Pharmaceuticals (ADMP) Following Announced US Compounding Acquisition
-
BioPharmX (BPMX) Plans Common Stock, Warrants Offering
-
BioPharmX Corporation Announces Proposed Public Offering of Common Stock and Warrants
-
Quantum Genomics Raises €8.6 Million in U.S. and Europe
-
Maxim Group Downgrades Chipotle Mexican Grill (CMG) to Sell
-
ContraFect (CFRX) PT Trimmed to $7 at Maxim Group as Results Awaited
-
GEF Acquisition Corporation Files Registration Statement for Initial Public Offering
-
StemCells, Inc. Announces Closing of $8 Million Public Offering
-
Intec Pharma Reports 2015 Fourth Quarter and Full-Year Financial Results
-
Maxim Group Upgrades Agenus Inc. (AGEN) to Buy
-
Pre-Open Stock Movers 03/11 (SSKN) (FNSR) (ULTA) Higher; (FXCM) (SGY) (RUN) Lower (more...)
-
Athersys (ATHX) PT Doubled to $10 at Maxim Group

